A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
HRYZ Biotech Co.
HRYZ Biotech Co.
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center